Intavis AG

Intavis AG

INTAVIS developes, produces and sells peptide synthesizers, which are continously improved because of their in-house use in production of peptides that are being sold worldwide.

INTAVIS is a leading company in the development and manufacturing of customized systems to automate complex protocols in biochemistry and molecular biology as well as synthesis of peptides of highest complexity and purity. INTAVIS' over 15 years of experience in application driven development and multiple facilities in Germany and the USA as well as a global distribution network guarantee the highest levels of competence and reliability in the creation of customer oriented solutions for complex problems in the biotechnological fields of peptide synthesis, proteomics and in-situ detection. The company is dedicated to the continuous development of techniques and instruments for biomolecular and pharmaceutical research as well as synthesis and analysis of biomolecules.

Category

Biotechnology

Activity Biotechnology, Chemistry, Development, Research, Oncology

Management

Dr. Steffen Hüttner (CEO)

Year of foundation

2000

Employees

23

Supervisory board

Dr. Peter Beck
Dr.Erik Silcher
Jürgen Wagner

Funding

private

News

29.10.2019

CEM Corporation acquires key assets of Intavis Bioanalytical Instruments

Matthews, N.C. October 25th, 2019 – CEM Corporation today announced that it has entered into a definitive agreement to purchase the instrumentation lines of Intavis…